---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-055304"
form_type: "8-K"
ticker: "ELAB"
cik: "0001840563"
company_name: "PMGC Holdings Inc."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T03:23:16.809251+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PMGC signs LOI to acquire profitable CNC shop; Northstrive advances obesity AI collaboration

## Summary
- LOI to acquire California CNC shop with $1.4M revenue, $215K adjusted EBITDA in 2024; AS9100D & ISO 9001:2015 certified.
- Target has 35+ years history; third pending acquisition since April 2025, consistent with PMGC's M&A strategy.
- Closing subject to due diligence, approvals, and definitive documentation; non-binding agreement.
- Northstrive initiates Phase II with Yuva Biosciences using MitoNova AI to select small molecules for obesity and cardiac diseases.
- Phase II aims to compile candidates for muscle preservation and metabolic health; builds on prior collaboration.

## SEC filing metadata
- accession: 0001213900-25-055304
- form_type: 8-K
- ticker: ELAB
- cik: 0001840563
- company_name: PMGC Holdings Inc.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840563/000121390025055304/0001213900-25-055304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840563/000121390025055304/ea0245676-8k_pmgc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-055304
- JSON: https://secwatch.observer/filing/0001213900-25-055304.json
- Plain text: https://secwatch.observer/filing/0001213900-25-055304.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.